Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00807
|
|||||
| Drug Name |
Sipatrigine
|
|||||
| Synonyms |
130800-90-7; 2-(4-Methyl-1-piperazinyl)-5-(2,3,5-trichlorophenyl)-4-pyrimidinamine; 2-(4-methylpiperazin-1-yl)-5-(2,3,5-trichlorophenyl)pyrimidin-4-amine; 4-Amino-2-(4-methyl-1-piperazinyl)-5-(2,3,5-trichlorophenyl)pyrimidine; 4-Pyrimidinamine, 2-(4-methyl-1-piperazinyl)-5-(2,3,5-trichlorophenyl)-; 619C89; AC1L1TYB; AC1Q3LMC; BW 619C89; BW-619C89; BW619C89; C16H17Cl3N4; CHEBI:34977; CHEMBL28854; DTXSID20156750; MLS006010764; MolPort-023-277-047; OON9AVW1T3; SCHEMBL135888; Sipatrigine; Sipatrigine [INN:BAN]; UNII-OON9AVW1T3
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C15H16Cl3N5
|
|||||
| Canonical SMILES |
CN1CCN(CC1)C2=NC=C(C(=N2)N)C3=C(C(=CC(=C3)Cl)Cl)Cl
|
|||||
| InChI |
InChI=1S/C15H16Cl3N5/c1-22-2-4-23(5-3-22)15-20-8-11(14(19)21-15)10-6-9(16)7-12(17)13(10)18/h6-8H,2-5H2,1H3,(H2,19,20,21)
|
|||||
| InChIKey |
PDOCBJADCWMDGL-UHFFFAOYSA-N
|
|||||
| Pharmaceutical Properties | Molecular Weight | 372.7 | Topological Polar Surface Area | 58.3 | ||
| Heavy Atom Count | 23 | Rotatable Bond Count | 2 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 5 | |||
| XLogP |
3.6
|
|||||
| PubChem CID | ||||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.